McKesson Corporation (MCK) Stock Price, Quote & AI Analysis

Live MCK stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for McKesson Corporation.

TradeVae provides AI-driven analysis and real-time market intelligence for McKesson Corporation (MCK), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

MCK
McKesson Corporation
real-time
$0.00 +0.00 (+0.00%)
Open
751.560000
High
759.090000
Low
747.500000
Volume
902,636
VWAP
-
Market Cap
$102,593,465,746.50
52W Range
$637.00 - $999.00
P/E Ratio
-
EPS
-
Dividend Yield
42.87%
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 4, 2026 Q1
Market
EPS Estimate: $9.8075
Revenue Estimate: $107,075,147,980.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

McKesson Corporation's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

McKesson Corporation Overview

Company information

Company Overview

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Company Details
Market Cap
$90.99B
Shares Outstanding
120,204,061
Weighted Shares Outstanding
123,426,650
CEO
Brian Scott Tyler
Address
6555 STATE HIGHWAY 161, IRVING, TX, 75039
Employees
51,000
Industry
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

McKesson Corporation Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...